Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer

Detailed information on mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis, based on the latest scientific studies.

Cancers, Free Full-Text

A novel oncogenic enhancer of estrogen receptor-positive breast cancer - ScienceDirect

Triple Negative Breast Cancer—Review of Current and Emerging Therapeutic Strategies - touchONCOLOGY

Estrogen/Progesterone Receptors (ER/PR Receptors)

Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer

Imaging Test to Guide Breast Cancer Treatment - NCI

Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells - ScienceDirect

Schematic figure summarizing breast cancer subtypes based on their

ER+/PR+ Breast Cancer Characteristics

A: Breast cancer comprises four subtypes defined by the positive (+)